Real world COPD: association of morning symptoms with clinical and patient reported outcomes.
about
Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary diseaseTiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial AsthmaIs aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications.Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study.Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary diseaseAclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies.Symptoms and quality of life in patients with chronic obstructive pulmonary disease treated with aclidinium in a real-life setting.Health Status of Patients With Chronic Obstructive Pulmonary Disease by Symptom LevelMorning symptoms in COPD: a treatable yet often overlooked factor.Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG.The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use: Results from an Observational Study (ASSESS).Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management.Understanding the impact of symptoms on the burden of COPD.Daily Symptom Variability in Patients With Stable COPD: A Narrative Review.The development and first validation of the Manchester Early Morning Symptoms Index (MEMSI) for patients with COPD.The association between objectively measured physical activity and morning symptoms in COPD.Inhaled therapies in patients with moderate COPD in clinical practice: current thinking.Long-term Recording of Night-Time Respiratory Symptoms in Patients with Stable COPD II-IV.The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPD.Physical activity in the morning and afternoon is lower in patients with chronic obstructive pulmonary disease with morning symptoms.Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis.
P2860
Q26770504-0347B085-4A89-4395-8024-2B7B37EFD6FEQ26780553-C55F7DEA-FFDE-4233-A1A6-69F61C867CBCQ30365242-07EBB50F-6668-4864-B3B1-5336CD3FEBB2Q33736509-192FFAB9-0074-4B68-9E13-99CDD5AD415BQ34451879-B9633450-CAD8-4C8A-8028-64B21FFEA80AQ34944547-D40A8BB9-A736-4756-898B-74FA135A78FDQ35201521-AFC0193F-2BBF-453E-A5CE-4307432FA113Q35937943-9DF9DA25-A9AE-4850-A03D-BFA412622DBFQ36929677-C92A19D0-E5C8-4F1F-8253-D46E5894309DQ37077371-63B304F2-A57E-4590-9DDE-44ACCFE6C147Q38604633-076B60A5-A776-474F-85B4-D5FE41049522Q38747579-F6103240-39E3-4E5E-B387-C43526FE9E3EQ38839252-3EFA793A-361C-43AC-AAC3-40730A83C231Q38894424-347CBB33-AFB1-430B-B5B0-1F14F54E0989Q39040871-3391ED7C-DBC1-4B1F-B472-24D3805FF2E5Q39255209-528A05A4-6743-4FAD-9096-387D97379084Q39274869-1742E248-0E49-45E4-90F0-3FB86E323436Q41696087-A436FE6F-5BAF-4878-A88E-B4FA8A596C77Q42373150-131028A3-7A10-4499-A88F-9A97D0122F9FQ47661714-2CB7C62C-9109-4392-A1EB-1BEC83A0C477Q47709019-CC4774A7-0011-463B-8290-5EE4502EF751Q55230990-612F37F2-F924-48A8-B4EF-C5BC3DD4FDF8Q55248953-B6E73863-C505-4256-AD8C-C56FFAC9A88FQ55467238-12921EB8-0D0C-49D1-96D4-D60CEC453BE6
P2860
Real world COPD: association of morning symptoms with clinical and patient reported outcomes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Real world COPD: association o ...... and patient reported outcomes.
@en
Real world COPD: association o ...... and patient reported outcomes.
@nl
type
label
Real world COPD: association o ...... and patient reported outcomes.
@en
Real world COPD: association o ...... and patient reported outcomes.
@nl
prefLabel
Real world COPD: association o ...... and patient reported outcomes.
@en
Real world COPD: association o ...... and patient reported outcomes.
@nl
P2093
P2860
P1476
Real world COPD: association o ...... and patient reported outcomes.
@en
P2093
Mark Small
Ryan Pollard
Sarah Broomfield
Victoria Higgins
P2860
P304
P356
10.3109/15412555.2013.844784
P407
P577
2013-10-15T00:00:00Z